XML 324 R85.htm IDEA: XBRL DOCUMENT v3.22.2.2
Related party transactions (Tables)
12 Months Ended
Jun. 30, 2022
Related party transactions  
Schedule of material related party transactions

    

2022

    

2021

    

2020

for the year ended 30 June

Rm

Rm

Rm

Sales and services rendered from subsidiaries to related parties

Joint ventures

 

2 737

 

2 635

 

672

Purchases by subsidiaries from related parties

 

  

 

  

 

  

Joint ventures

 

4

 

8

 

691

Associates

 

153

 

100

 

78

 

157

 

108

 

769

Schedule of key management remuneration

    

    

    

Retirement

    

Other

    

Annual

Total

    

Total

    

Total

Salary

funding

benefits

incentives2

20221

20211

20201

R’000

R’000

R’000

R’000

R’000

R’000

R’000

EXECUTIVE DIRECTORS

 

26 980

 

764

 

2 948

 

22 691

53 383

 

65 493

 

22 944

1Total remuneration for the financial year excludes gains derived from the long-term incentive schemes which are separately disclosed.
2Short-term incentives approved based on the Group results for the 2022 financial year and payable in the 2023 financial year. Incentives are calculated as a percentage of total guaranteed package/base salary as at 30 June 2022 multiplied by the Group STI performance and the Individual Performance Factor.

Gains on Long-term incentives previously awarded to the Executive Directors’ and former Executive Directors’ vested after the performance period ended 30 June 2022, are as follows:

    

    

    

    

Long-term

incentive

Total 

Total 

Total 

rights vested1

2022

2021

2020

R’000

R’000

R’000

R’000

EXECUTIVE DIRECTORS

 

30 850

 

30 850

 

4 824

 

2 657

1

Long-term incentives for the 2022 financial year represent incentives approved on the group results for theperformance period ended 30 June 2022, settled in the 2023 financial year.

37

Related party transactions continued

Remuneration and benefits paid and short-term incentives approved for the Prescribed Officers were as follows:

    

    

Retirement 

    

Other 

Annual

    

Total 

    

Total 

    

Total 

Salary 

funding 

benefits 

incentives2

20221

20211

20201

R’000

R’000

R’000

R’000

R’000

R’000

R’000

PRESCRIBED OFFICERS

 

38 060

5 312

 

16 751

28 349

 

88 472

 

92 817

 

52 142

Number of Prescribed Officers

 

  

 

  

 

  

 

8

 

7

 

6

1Total remuneration for the financial year excludes gains derived from the long-term incentive schemes which are separately disclosed.
2Short-term incentives approved based on the Group results for the 2022 financial year and payable in the 2023 financial year. Incentives are calculated as a percentage of total guaranteed package/base salary as at 30 June 2022 multiplied by the Group STI performance and the Individual Performance Factor.

Gains on Long-term incentives previously awarded to the Prescribed Officers vested after the performance period ended 30 June 2021, are as follows:

    

    

    

    

Long-term 

incentive 

rights 

Total 

Total 

Total 

vested1 

2022

2021

2020

R’000

R’000

R’000

R’000

PRESCRIBED OFFICERS

 

50 512

 

50 512

 

6 735

 

4 201

1

Long-term incentives for the 2022 financial year represent incentives approved on the group results for the performance period ended 30 June 2022, settled in the 2023 financial year.

The total IFRS2 charge for LTI’s awarded to the Executive Directors and the Prescribed Officers in 2022 amounted to R14 million and R32 million.

Non-executive Directors’ emoluments for the year was as follows:

    

    

    

    

Ad Hoc 

    

    

    

Special 

Board 

Lead 

Board — 

meeting 

Director 

Committee 

Committee

Total 

Total 

Total 

fees 

fees 

fees 

 Meeting 

2022

2021

2020

R’000

R’000

R’000

R’000

R’000

R’000

R’000

Non-executive Directors

22 787

 

758

 

6 861

 

30 406

 

33 540

 

39 743